Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now?
From Yahoo Finance: 2025-04-18 17:46:00
Journey Medical Corporation (NASDAQ:DERM) is among the 10 Cheap Hot Stocks to Buy Right Now, standing out in a list of attractively priced stocks. Analysts Jim Tierney and Kathy Jones shared advice on navigating the current market volatility, emphasizing the importance of sticking to fundamental investment principles during uncertain times. Jones advised diversified, credit-quality-focused fixed income portfolios for income-seeking long-term investors.
Tierney encouraged equity investors to be selective in seeking opportunities despite market uncertainty. He suggested focusing on companies capable of double-digit growth over the next 5 years, especially those with local manufacturing to avoid tariff risks. The recent market rebound shouldn’t prompt investors to sell, as slightly lower prices may offer better entry points for long-term gains.
Journey Medical Corporation (NASDAQ:DERM) has a Forward P/E Ratio of 14.16 and has gained 16.95% in the past month. The company develops and commercializes pharmaceutical products for dermatological conditions, with a focus on products like Qbrexza, Accutane, and Amzeeq. Its near-term revenue depends on the launch and market adoption of MROSI, a newly FDA-approved oral treatment for rosacea.
Journey Medical Corporation (NASDAQ:DERM) made significant one-time payments to bring MROSI to market, with immediate market access efforts yielding coverage for a portion of commercial and Medicare lives. The product has the potential to achieve $200 million in annual sales in the US and $100 million internationally in 2025. While DERM ranks 10th on the list of cheap hot stocks, there is a promising AI stock that may offer higher returns trading at less than 5 times its earnings.
Read more: Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now?